Financhill
Back

BioXcel Therapeutics Vs. MSCI Industry Stock Comparison

Sell
24

BTAI
BioXcel Therapeutics

Last Price:
2.57
Seasonality Move:
-0.19%
Sell
33

MSCI
MSCI

Last Price:
467.02
Seasonality Move:
9.49%
Sell
24
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $2.57. The Score for BTAI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
MSCI (MSCI) is a Sell

Is MSCI a Buy, Sell or Hold?

  • The current MSCI [MSCI] share price is $467.04. The Score for MSCI is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • MSCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $2.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.

MSCI Stock Price Chart

What is MSCI's stock price today?

  • The MSCI share price today is $467.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSCI is experiencing selling pressure, which indicates risk of future bearish movement.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 43.88 Sell
Chaikin Money Flow: -120721 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.55 - 2.79) Sell
Bollinger Bands (100): (2.58 - 3.26) Sell

MSCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -21.06 Sell
Relative Strength Index (14 RSI): 34.09 Sell
Chaikin Money Flow: -691386 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (473.82 - 540.64) Sell
Bollinger Bands (100): (514.54 - 578.04) Sell

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.59 Sell
20-day SMA: 2.67 Sell
50-day SMA: 2.81 Sell
200-day SMA: 3.69 Sell
8-day EMA: 2.6 Sell
20-day EMA: 2.66 Sell
50-day EMA: 2.79 Sell
200-day EMA: 5.44 Sell

MSCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 469.31 Sell
20-day SMA: 498.39 Sell
50-day SMA: 532.53 Sell
200-day SMA: 533.71 Sell
8-day EMA: 473.34 Sell
20-day EMA: 493.19 Sell
50-day EMA: 520.48 Sell
200-day EMA: 528.99 Sell

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.16 per share.

MSCI Earnings Growth & MSCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.39 per share, an increase this year of $1.63 per share, and an increase next year of $2.01 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MSCI Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):